Is this you? Create Your Porfile
Avatar

Karl Dr. Rudolphi

Aventis Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Karl Dr. Rudolphi is active.

Explore More

Publication

Featured researches published by Karl Dr. Rudolphi.

Archive | 1992

Use of xanthine derivatives for the manufacture of a medicament for the treatment of secondary nerve cell damages and function disorders after head-brain-traumata

Hans-Peter Schubert; John J. Grome; Barbara Dr. Kittner; Karl Dr. Rudolphi; Ulrich Dr Gebert

Archive | 1997

Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof

Ulrich Gebert; Erhard Dr. Wolf; Elisabeth Defossa; Uwe Heinelt; Hiristo Anagnostopulos; Karl Dr. Rudolphi; John J. Grome

Archive | 1998

Kombinationspräparat zur Anwendung bei Demenz, enthaltend mindestens eine Verbindung die eine Acetylcholinesterase-Hemmwirkung oder muskarinerge Wirkung zeigt und eine Verbindung die den endogenen extrazellulären Adenosinspiegel erhöht

Hildegard Nimmesgern; Karl Dr. Rudolphi; Hans-Peter Schubert

Archive | 1998

Combinatory compositions for the treatment of dementia containing at least a compound having acetylcholinesterase-inhibitory or muscarinic activity and a compound that enhances the endogenous extracellular adenosine levels

Hildegard Nimmesgern; Karl Dr. Rudolphi; Hans-Peter Schubert

Archive | 1998

Compositions combinées pour le traitement de la démence contenant au moins un produit à effet inhibiteur de acetylcholinestérase ou muscarinique et un produit qui accroit le niveau d'adénosine endogène extracellular

Hildegard Nimmesgern; Karl Dr. Rudolphi; Hans-Peter Schubert

Archive | 1998

PREPARADO DE COMBINACION PARA EL TRATAMIENTO DE LA DEMENCIA, QUE CONTIENE AL MENOS UN COMPUESTO QUE TIENE ACTIVIDAD INHIBIDORA DE LA ACETILCOLINESTERASA O MUSCARINICA Y UN COMPUESTO QUE AUMENTA LOS NIVELES DE ADENOSINA ENDOGENA EXTRACELULAR.

Hildegard Nimmesgern; Karl Dr. Rudolphi; Hans-Peter Schubert

Archive | 1997

Xanthinforbindelser med terminalt aminerede alkynolsidekæder

Ulrich Gebert; Elisabeth Defossa; Uwe Heinelt; Karl Dr. Rudolphi; John J. Grome

Archive | 1997

Verwendung von Theophyllinderivaten zur Behandlung und Propylaxe von Schockzuständen, neue Xanthinverbindungen und Verfahren zu deren Herstellung

Hiristo Anagnostopulos; Elisabeth Defossa; Ulrich Gebert; John J. Grome; Uwe Heinelt; Karl Dr. Rudolphi; Erhard Dr. Wolf

Archive | 1997

Xanthine derivatives with end-aminated alkynol side chains

Ulrich Gebert; Elisabeth Defossa; Uwe Heinelt; Karl Dr. Rudolphi; John J. Grome

Archive | 1997

Xanthinverbindungen mit terminal aminierten Alkinol-Seitenketten

Ulrich Gebert; Elisabeth Defossa; Uwe Heinelt; Karl Dr. Rudolphi; John J. Grome

Explore More

Collaboration

Dive into the Karl Dr. Rudolphi's collaboration.

Top Co-Authors
Avatar

John J. Grome

University of Glasgow

View shared research outputs
Top Co-Authors
Avatar

Uwe Heinelt

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Elisabeth Defossa

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Hans-Peter Schubert

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Hildegard Nimmesgern

Aventis Pharma

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge